covid 19 News and Research

RSS

Portable PDT device could pave the way for at-home treatment of basal cell carcinoma

A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a hospital stay. These findings come from a breakthrough pilot study, presented today at the 30th EADV Congress.

1 Oct 2021

Similar viral load in vaccinated and unvaccinated individuals infected with SARS-CoV-2 Delta variant

Researchers evaluated Ct-values among distinct groups, namely, a) completely vaccinated and unvaccinated individuals and b) asymptomatic and symptomatic individuals at the time of testing.

1 Oct 2021

The extent to which COVID-19 vaccination reduces transmission varies with vaccine type and SARS-CoV-2 strain

Researchers from the University of Oxford have been examining the impact of vaccination on the spread of the Alpha and Delta variants through the population.

1 Oct 2021

Study finds US pediatric COVID-19 cases are higher than expected

Researchers from the CDC have investigated differences in seroprevalence across pediatric age groups to estimate an infection to case ratio.

1 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Real-world data looking at biologic treatment and vaccine hesitancy in psoriasis patients is being presented today at EADV’s 30th Congress.

1 Oct 2021

New report evaluates the impact of climate change on health

Tomorrow, Wednesday 29th September, the Action for Global Health network will release a new report on “Health Inequalities and Climate Change”, calling for ambitious action to tackle climate change for the health of people and the planet.

1 Oct 2021

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

The number of colorectal cancer cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown.

1 Oct 2021

Effective active learning methods improve academic performance of students

Engaging students through interactive activities, discussions, feedback, and AI-enhanced technologies resulted in improved academic performance compared to traditional lectures, lessons, or readings, faculty from Carnegie Mellon University's Human-Computer Interaction Institute concluded after collecting research into active learning.

1 Oct 2021

COVID-19 lockdowns have stunted the development of schoolchildren

This month the few remaining countries in East Asia and the Pacific that had kept schools shuttered since the COVID-19 outbreak are reopening, some on a limited scale.

1 Oct 2021

Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

Is one COVID vaccine better than the other? Four current vaccines — Moderna, Pfizer-BioNTech, Johnson & Johnson, and AstraZeneca — are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but a new medRxiv* study suggests the level of protection varies.

30 Sep 2021

New approach reveals ‘protein partners’ that may contribute to unusual pathologies of COVID-19

COVID-19 not only causes symptoms characteristic of a typical respiratory disorder, but has also been known to trigger a wide range of other symptoms in people who had been infected, some lasting even long after individuals test negative for the virus.

30 Sep 2021

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding.

30 Sep 2021

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.

30 Sep 2021

University of Oxford and Oracle's Global Pathogen Analysis System helping researchers to combat COVID-19

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.

30 Sep 2021

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

30 Sep 2021

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

A team of scientists from the USA and France has recently unveiled the mechanism of immune dysregulation in coronavirus disease 2019 (COVID-19) patients by analyzing the early-stage interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected epithelial cells and immune cells. The study is currently available on the bioRxiv* preprint server.

30 Sep 2021

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

If immigrants to the United States formed their own country, their pre-COVID-19 life expectancies would exceed or match those of the world's leaders in longevity - Swiss men and Japanese women.

30 Sep 2021

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

30 Sep 2021

Rise of the Delta variant increases COVID-19 hospitalizations among unvaccinated pregnant women

Unvaccinated pregnant women are increasingly being hospitalized with COVID-19 during a nationwide surge of the Delta variant, according to research from UT Southwestern Medical Center.

30 Sep 2021

covid 19 News and Research

Portable PDT device could pave the way for at-home treatment of basal cell carcinoma

Similar viral load in vaccinated and unvaccinated individuals infected with SARS-CoV-2 Delta variant

The extent to which COVID-19 vaccination reduces transmission varies with vaccine type and SARS-CoV-2 strain

Study finds US pediatric COVID-19 cases are higher than expected

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

New report evaluates the impact of climate change on health

Research shows dramatic decline in colorectal cancer diagnoses during the pandemic

Effective active learning methods improve academic performance of students

COVID-19 lockdowns have stunted the development of schoolchildren

Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

New approach reveals ‘protein partners’ that may contribute to unusual pathologies of COVID-19

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

University of Oxford and Oracle's Global Pathogen Analysis System helping researchers to combat COVID-19

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

Rise of the Delta variant increases COVID-19 hospitalizations among unvaccinated pregnant women

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News